NASDAQ:BIOX - Nasdaq - KYG1117K1141 - Common Stock - Currency: USD
Bioceres Crop (BIOX) delivered earnings and revenue surprises of 80% and 3.56%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: AVO
Cibus (CBUS) delivered earnings and revenue surprises of -5.71% and 12.37%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: CBUS
An Argentine crop developer that is the first to receive US approval for genetically modified wheat said it will take years to bring the technology to market.
The Biden administration says Bioceres Crop Solutions Corp.’s drought-tolerant grain trait doesn’t require regulation, putting the agriculture technology company a step closer to its goal of bringing the first genetically modified wheat to global markets.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bioceres Crop Solutions (NASDAQ:BIOX) just reported results for the third quart...
BIOX stock results show that Bioceres Crop Solutions missed analyst estimates for earnings per share and missed on revenue for the third quarter of 2024.